[1]
“Recurrence patterns in patients with advanced non-small cell lung cancer who have received epidermal growth factor receptor tyrosine kinase inhibitors”, Eur J Oncol, vol. 21, no. 3, pp. 169–173, Dec. 2016, Accessed: Jul. 18, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/EJOEH/article/view/4475